+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bioabsorbable Stents Market - Global Forecast 2026-2032- Product Image
Bioabsorbable Stents Market - Global Forecast 2026-2032- Product Image
Sale

Bioabsorbable Stents Market - Global Forecast 2026-2032

  • Report

  • 185 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6011334
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Bioabsorbable Stents Market is projected to reach USD 645.65 Million in 2026. It is expected to continue growing at a CAGR of 6.63%, reaching USD 952.71 Million by 2032.

Bioabsorbable stents, also known as bioresorbable vascular scaffolds, are designed to provide temporary vessel support after percutaneous coronary intervention and then gradually degrade, potentially restoring vasomotion and reducing the long-term presence of permanent metallic implants. The category remains clinically important because cardiovascular disease continues to be the world’s leading cause of death, with the World Health Organization estimating about 17.9 million deaths annually from cardiovascular conditions.

The bioabsorbable stents market is shaped by a clear evidence threshold. Early enthusiasm moderated after first-generation polymeric scaffolds showed higher risks of scaffold thrombosis in some studies, and a leading first-generation scaffold was withdrawn from global commercial availability in 2017. Current growth is therefore driven less by broad replacement of contemporary drug-eluting stents and more by targeted innovation in thinner struts, improved deployment protocols, magnesium-based platforms, advanced imaging guidance, and rigorously selected patient populations.

Transformative Shifts in the Bioabsorbable Stents Landscape

The bioabsorbable stents landscape is shifting from concept-led commercialization toward evidence-led specialization. Developers are prioritizing thinner scaffold profiles, improved radial strength, controlled degradation kinetics, and drug-elution consistency to address the safety lessons of first-generation devices. This transition aligns with cardiology’s broader preference for proven clinical outcomes over device novelty, especially in coronary artery disease treatment.

Regulation is another major transformative force. Europe’s Medical Device Regulation has raised expectations for clinical evidence and post-market surveillance, while the United States maintains a high bar for premarket approval of coronary scaffold technologies. In Asia-Pacific, local innovation in China, India, Japan, and South Korea is increasing competitive intensity, particularly where domestic manufacturing policies, rising procedure capacity, and large coronary artery disease burdens support clinical research and technology localization.

Cumulative Impact of Artificial Intelligence on Bioabsorbable Stents

Artificial intelligence is influencing bioabsorbable stents across the full value chain, from biomaterial design to real-world evidence generation. AI-assisted simulation can help evaluate scaffold geometry, radial strength, degradation behavior, and drug-release profiles before extensive bench or animal testing. This can shorten iteration cycles while improving the probability that designs meet safety, deliverability, and procedural performance requirements.

In clinical practice, AI-enabled intravascular imaging and angiographic analysis can support lesion assessment, vessel sizing, scaffold expansion, and post-procedure optimization. These factors are particularly important for bioabsorbable scaffolds because implantation technique and patient selection strongly affect outcomes. Machine learning applied to registries, claims data, and follow-up imaging can also strengthen post-market surveillance by detecting safety signals earlier, refining indications, and improving evidence quality for bioresorbable vascular scaffolds.

Key Regional Insights for Bioabsorbable Stents

Asia-Pacific is emerging as a strategic arena for bioabsorbable stents because of high cardiovascular disease prevalence, expanding catheterization infrastructure, and strong domestic device ecosystems in China, India, Japan, and South Korea. China’s regulatory modernization and hospital investment support local clinical evaluation, while India’s large patient base and price-sensitive market create demand for cost-efficient scaffold platforms with clear clinical value. Japan and South Korea add advanced imaging adoption, rigorous quality expectations, and strong clinical research capabilities, making the region important for next-generation bioresorbable vascular scaffold development.

North America remains a premium evidence-generation region, led by the United States and Canada, but adoption is constrained by strict regulatory standards and limited routine use of coronary bioresorbable scaffolds after first-generation safety concerns. Europe has historically been important for CE-marked technologies, yet the EU Medical Device Regulation has intensified clinical documentation, post-market follow-up, and safety surveillance requirements. Latin America, led by Brazil and Mexico, presents selective opportunities in tertiary cardiac centers where private healthcare access and specialist interventional cardiology capacity are stronger. The Middle East, especially GCC countries, is investing in advanced hospital infrastructure, cardiovascular programs, and medical tourism, while Africa remains a longer-term opportunity due to uneven cath lab access, affordability constraints, and the need for scalable cardiovascular care pathways.

Key Group Insights for Bioabsorbable Stents

ASEAN offers a mixed but promising environment for bioabsorbable stents, with Singapore, Malaysia, Thailand, Indonesia, and Vietnam showing different levels of reimbursement maturity, hospital capacity, and regulatory readiness. Premium bioresorbable vascular scaffolds are most likely to gain traction first in advanced urban cardiac centers where imaging-guided PCI, trained interventional cardiologists, and structured follow-up programs are available. ASEAN demand is also shaped by the region’s rising burden of diabetes, hypertension, and ischemic heart disease, which increases the need for durable cardiovascular care models.

The GCC is positioned as a high-value adoption cluster due to continued investment in tertiary hospitals, cardiovascular centers, and medical tourism infrastructure. The European Union is central for regulatory credibility, but MDR compliance increases the importance of clinical evidence, post-market follow-up, and quality management systems. BRICS countries combine large coronary disease burdens with growing domestic manufacturing capabilities, making them important for localized production, clinical trials, and affordability-focused innovation. G7 markets remain critical for scientific validation, reimbursement evidence, and guideline influence, while NATO countries increasingly emphasize medical supply-chain resilience, trusted sourcing, and continuity of access for critical health technologies.

Key Country Insights for Bioabsorbable Stents

The United States is the most influential country for clinical validation, reimbursement evidence, regulatory credibility, and investor confidence, although scrutiny remains high after first-generation scaffold safety concerns. Canada follows a conservative, evidence-based adoption model shaped by health technology assessment and provincial procurement priorities, while Mexico offers opportunities through private hospitals, urban specialty centers, and cross-border specialty care. Brazil is Latin America’s primary interventional cardiology market and a key site for regional commercialization, supported by a large cardiovascular disease burden and established tertiary hospital networks.

In Europe, the United Kingdom, Germany, France, Italy, and Spain combine advanced PCI capacity with strong health technology assessment discipline, physician training standards, and post-market evidence expectations, while Russia presents opportunities tempered by geopolitical, procurement, and supply-chain uncertainty. China is scaling domestic cardiovascular innovation through hospital expansion, regulatory reform, and local device development, while India offers a large patient base and cost-sensitive demand that favors differentiated clinical value and affordability. Japan maintains strict quality expectations through PMDA review and careful clinical adoption, Australia supports evidence-led specialty use through advanced cardiac centers, and South Korea contributes strong medtech manufacturing, hospital digitization, intravascular imaging use, and clinical research capabilities.

Actionable Recommendations for Industry Leaders

Industry leaders should focus on clinically differentiated indications rather than broad substitution of contemporary drug-eluting stents. The strongest strategies will pair improved scaffold design with imaging-guided implantation protocols, physician training, and long-term follow-up data that directly address scaffold thrombosis, restenosis, target lesion failure, and late adverse events.

Organizations should invest in AI-enabled design validation, real-world evidence platforms, and registry-based safety monitoring. Commercial teams should prioritize markets with advanced cath lab infrastructure, predictable reimbursement, experienced interventional cardiology networks, and regulators receptive to robust clinical evidence. Partnerships with hospitals, academic centers, and local manufacturers can improve trial recruitment, localization, training, and market access, especially in Asia-Pacific, GCC countries, and selected BRICS economies.

Research Methodology

This executive summary is built on a structured secondary research approach using verified sources, including public health data from the World Health Organization, regulatory information from agencies such as the U.S. FDA and European authorities, peer-reviewed clinical literature on bioresorbable vascular scaffolds, and publicly available product and regulatory disclosures. The assessment emphasizes documented clinical, regulatory, technological, and commercial developments rather than speculative market claims.

The analysis applies triangulation across clinical outcomes, reimbursement dynamics, regional healthcare infrastructure, technology readiness, regulatory requirements, and competitive positioning. Particular attention is given to lessons from first-generation bioabsorbable stents, current evidence requirements, post-market surveillance expectations, and the role of AI, imaging, and biomaterials innovation in improving next-generation bioabsorbable stent performance.

Conclusion

The bioabsorbable stents market is entering a more disciplined phase defined by clinical evidence, patient selection, and technology refinement. While earlier devices exposed meaningful safety and adoption challenges, the underlying clinical rationale for temporary vascular scaffolding remains relevant where long-term metallic caging may be undesirable and where lesion characteristics support careful use.

Future success will depend on safer materials, thinner profiles, reliable degradation, AI-supported development, optimized implantation techniques, and high-quality post-market evidence. Stakeholders that align innovation with regulatory expectations, interventional cardiology workflows, physician training, and regional affordability realities will be best positioned to capture sustainable opportunities in the evolving bioabsorbable stents market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Bioabsorbable Stents Market, by Material
7.1. Introduction
7.2. Metal-based Bioabsorbable Stents
7.2.1. Iron-based
7.2.2. Magnesium-based
7.2.3. Zinc-based Alloys
7.3. Polymer-based Bioabsorbable Stents
7.3.1. Poly-L-lactic acid (PLLA)
7.3.2. Polycaprolactone (PCL)
7.3.3. Polydioxanone (PDO)
7.3.4. Polyglycolic acid (PGA)
8. Bioabsorbable Stents Market, by Product Type
8.1. Introduction
8.2. Drug-Eluting
8.3. Non-Drug-Eluting
9. Bioabsorbable Stents Market, by Degradation Time
9.1. Introduction
9.2. 12-24 months
9.3. Less than 12 months
9.4. More than 24 months
10. Bioabsorbable Stents Market, by Application
10.1. Introduction
10.2. Coronary Artery Disease (CAD)
10.3. Neurovascular Disease
10.4. Pediatric Applications
10.5. Peripheral Artery Disease (PAD)
11. Bioabsorbable Stents Market, by End User
11.1. Introduction
11.2. Academic & Research Institutions
11.3. Ambulatory Surgical Centers
11.4. Cardiac Centers
11.5. Hospitals
12. Bioabsorbable Stents Market, by Distribution Channel
12.1. Introduction
12.2. Offline
12.3. Online
13. Bioabsorbable Stents Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Bioabsorbable Stents Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Bioabsorbable Stents Market, by Country
15.1. Introduction
15.2. United States
15.3. China
15.4. Germany
15.5. United Kingdom
15.6. India
15.7. Japan
15.8. France
15.9. Brazil
15.10. Canada
15.11. Italy
15.12. Mexico
15.13. Russia
15.14. Spain
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Abbott Laboratories
17.2. Amaranth Medical, Inc.
17.3. Arterius Ltd
17.4. B. Braun SE
17.5. BIOTRONIK SE & Co. KG
17.6. Boston Scientific Corporation
17.7. Cardionovum GmbH
17.8. Elixir Medical Corporation
17.9. ELLA - CS, s.r.o.
17.10. JW Medical Systems Ltd. Biosensors International Group, Ltd.
17.11. Kaneka Corporation
17.12. Kyoto Medical Planning Co. Ltd.
17.13. Lepu Medical Technology Co. Ltd.
17.14. Meril Life Sciences
17.15. Microport Scientific Corporation
17.16. OrbusNeich Medical Group Holdings Limited
17.17. Q3 Medical Group
17.18. Reva Medical
17.19. SafeGuard Surgical, Inc.
17.20. Shandong Hua'an Biotechnology
17.21. Sino Medical Sciences Technology Inc.
17.22. Svelte Medical Systems Inc
17.23. Terumo Corporation
17.24. WEGO HEALTHCARE (SHENZHEN) CO., LTD
17.25. Zorion Medical Inc.
18. Key Experts
List of Figures
FIGURE 1. Global Bioabsorbable Stents Market, Years Considered for the Study
FIGURE 2. Global Bioabsorbable Stents Market, Research Design
FIGURE 3. Global Bioabsorbable Stents Market, Research Framework
FIGURE 4. Global Bioabsorbable Stents Market, Data Triangulation
FIGURE 5. Global Bioabsorbable Stents Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Bioabsorbable Stents Market Size, by Material, 2025 vs 2032 (%)
FIGURE 7. Global Bioabsorbable Stents Market Size, by Material, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Bioabsorbable Stents Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 9. Global Bioabsorbable Stents Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Bioabsorbable Stents Market Size, by Degradation Time, 2025 vs 2032 (%)
FIGURE 11. Global Bioabsorbable Stents Market Size, by Degradation Time, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Bioabsorbable Stents Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Bioabsorbable Stents Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Bioabsorbable Stents Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Bioabsorbable Stents Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Bioabsorbable Stents Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 17. Global Bioabsorbable Stents Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Bioabsorbable Stents Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Bioabsorbable Stents Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Bioabsorbable Stents Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Bioabsorbable Stents Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Bioabsorbable Stents Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Bioabsorbable Stents Market Share, by Key Player, 2025
List of Tables
TABLE 1. Global Bioabsorbable Stents Market Segmentation & Coverage
TABLE 2. Global Bioabsorbable Stents Market Size, 2017-2032 (USD Million)
TABLE 3. Global Bioabsorbable Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 4. Global Metal-based Bioabsorbable Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Metal-based Bioabsorbable Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Metal-based Bioabsorbable Stents Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Iron-based Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Iron-based Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Iron-based Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Magnesium-based Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Magnesium-based Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Magnesium-based Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Zinc-based Alloys Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Zinc-based Alloys Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Zinc-based Alloys Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Polymer-based Bioabsorbable Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Polymer-based Bioabsorbable Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Polymer-based Bioabsorbable Stents Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Poly-L-lactic acid (PLLA) Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Poly-L-lactic acid (PLLA) Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Poly-L-lactic acid (PLLA) Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Polycaprolactone (PCL) Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Polycaprolactone (PCL) Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Polycaprolactone (PCL) Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Polydioxanone (PDO) Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Polydioxanone (PDO) Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Polydioxanone (PDO) Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Polyglycolic acid (PGA) Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Polyglycolic acid (PGA) Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Polyglycolic acid (PGA) Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Bioabsorbable Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 32. Global Drug-Eluting Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Drug-Eluting Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Drug-Eluting Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Non-Drug-Eluting Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Non-Drug-Eluting Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Non-Drug-Eluting Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Bioabsorbable Stents Market Size, by Degradation Time, 2017-2032 (USD Million)
TABLE 39. Global 12-24 months Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global 12-24 months Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global 12-24 months Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Less than 12 months Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Less than 12 months Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Less than 12 months Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global More than 24 months Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global More than 24 months Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global More than 24 months Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Bioabsorbable Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 49. Global Coronary Artery Disease (CAD) Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Coronary Artery Disease (CAD) Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Coronary Artery Disease (CAD) Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Neurovascular Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Neurovascular Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Neurovascular Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Pediatric Applications Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Pediatric Applications Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Pediatric Applications Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Peripheral Artery Disease (PAD) Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Peripheral Artery Disease (PAD) Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Peripheral Artery Disease (PAD) Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Bioabsorbable Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 62. Global Academic & Research Institutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Academic & Research Institutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Academic & Research Institutions Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Cardiac Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Cardiac Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Cardiac Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Bioabsorbable Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 75. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Bioabsorbable Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Asia-Pacific Bioabsorbable Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Asia-Pacific Bioabsorbable Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 84. Asia-Pacific Bioabsorbable Stents Market Size, by Metal-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 85. Asia-Pacific Bioabsorbable Stents Market Size, by Polymer-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 86. Asia-Pacific Bioabsorbable Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 87. Asia-Pacific Bioabsorbable Stents Market Size, by Degradation Time, 2017-2032 (USD Million)
TABLE 88. Asia-Pacific Bioabsorbable Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 89. Asia-Pacific Bioabsorbable Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 90. Asia-Pacific Bioabsorbable Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 91. North America Bioabsorbable Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. North America Bioabsorbable Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 93. North America Bioabsorbable Stents Market Size, by Metal-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 94. North America Bioabsorbable Stents Market Size, by Polymer-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 95. North America Bioabsorbable Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 96. North America Bioabsorbable Stents Market Size, by Degradation Time, 2017-2032 (USD Million)
TABLE 97. North America Bioabsorbable Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 98. North America Bioabsorbable Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 99. North America Bioabsorbable Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 100. Latin America Bioabsorbable Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Latin America Bioabsorbable Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 102. Latin America Bioabsorbable Stents Market Size, by Metal-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 103. Latin America Bioabsorbable Stents Market Size, by Polymer-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 104. Latin America Bioabsorbable Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 105. Latin America Bioabsorbable Stents Market Size, by Degradation Time, 2017-2032 (USD Million)
TABLE 106. Latin America Bioabsorbable Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 107. Latin America Bioabsorbable Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 108. Latin America Bioabsorbable Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 109. Europe Bioabsorbable Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Europe Bioabsorbable Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 111. Europe Bioabsorbable Stents Market Size, by Metal-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 112. Europe Bioabsorbable Stents Market Size, by Polymer-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 113. Europe Bioabsorbable Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 114. Europe Bioabsorbable Stents Market Size, by Degradation Time, 2017-2032 (USD Million)
TABLE 115. Europe Bioabsorbable Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 116. Europe Bioabsorbable Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 117. Europe Bioabsorbable Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 118. Middle East Bioabsorbable Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Middle East Bioabsorbable Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 120. Middle East Bioabsorbable Stents Market Size, by Metal-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 121. Middle East Bioabsorbable Stents Market Size, by Polymer-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 122. Middle East Bioabsorbable Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 123. Middle East Bioabsorbable Stents Market Size, by Degradation Time, 2017-2032 (USD Million)
TABLE 124. Middle East Bioabsorbable Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 125. Middle East Bioabsorbable Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 126. Middle East Bioabsorbable Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 127. Africa Bioabsorbable Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 128. Africa Bioabsorbable Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 129. Africa Bioabsorbable Stents Market Size, by Metal-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 130. Africa Bioabsorbable Stents Market Size, by Polymer-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 131. Africa Bioabsorbable Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 132. Africa Bioabsorbable Stents Market Size, by Degradation Time, 2017-2032 (USD Million)
TABLE 133. Africa Bioabsorbable Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 134. Africa Bioabsorbable Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 135. Africa Bioabsorbable Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 136. Global Bioabsorbable Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. ASEAN Bioabsorbable Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 138. ASEAN Bioabsorbable Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 139. ASEAN Bioabsorbable Stents Market Size, by Metal-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 140. ASEAN Bioabsorbable Stents Market Size, by Polymer-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 141. ASEAN Bioabsorbable Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 142. ASEAN Bioabsorbable Stents Market Size, by Degradation Time, 2017-2032 (USD Million)
TABLE 143. ASEAN Bioabsorbable Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 144. ASEAN Bioabsorbable Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 145. ASEAN Bioabsorbable Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 146. GCC Bioabsorbable Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 147. GCC Bioabsorbable Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 148. GCC Bioabsorbable Stents Market Size, by Metal-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 149. GCC Bioabsorbable Stents Market Size, by Polymer-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 150. GCC Bioabsorbable Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 151. GCC Bioabsorbable Stents Market Size, by Degradation Time, 2017-2032 (USD Million)
TABLE 152. GCC Bioabsorbable Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 153. GCC Bioabsorbable Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 154. GCC Bioabsorbable Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 155. European Union Bioabsorbable Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 156. European Union Bioabsorbable Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 157. European Union Bioabsorbable Stents Market Size, by Metal-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 158. European Union Bioabsorbable Stents Market Size, by Polymer-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 159. European Union Bioabsorbable Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 160. European Union Bioabsorbable Stents Market Size, by Degradation Time, 2017-2032 (USD Million)
TABLE 161. European Union Bioabsorbable Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 162. European Union Bioabsorbable Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 163. European Union Bioabsorbable Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 164. BRICS Bioabsorbable Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 165. BRICS Bioabsorbable Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 166. BRICS Bioabsorbable Stents Market Size, by Metal-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 167. BRICS Bioabsorbable Stents Market Size, by Polymer-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 168. BRICS Bioabsorbable Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 169. BRICS Bioabsorbable Stents Market Size, by Degradation Time, 2017-2032 (USD Million)
TABLE 170. BRICS Bioabsorbable Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 171. BRICS Bioabsorbable Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 172. BRICS Bioabsorbable Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 173. G7 Bioabsorbable Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 174. G7 Bioabsorbable Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 175. G7 Bioabsorbable Stents Market Size, by Metal-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 176. G7 Bioabsorbable Stents Market Size, by Polymer-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 177. G7 Bioabsorbable Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 178. G7 Bioabsorbable Stents Market Size, by Degradation Time, 2017-2032 (USD Million)
TABLE 179. G7 Bioabsorbable Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 180. G7 Bioabsorbable Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 181. G7 Bioabsorbable Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 182. NATO Bioabsorbable Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 183. NATO Bioabsorbable Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 184. NATO Bioabsorbable Stents Market Size, by Metal-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 185. NATO Bioabsorbable Stents Market Size, by Polymer-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 186. NATO Bioabsorbable Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 187. NATO Bioabsorbable Stents Market Size, by Degradation Time, 2017-2032 (USD Million)
TABLE 188. NATO Bioabsorbable Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 189. NATO Bioabsorbable Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 190. NATO Bioabsorbable Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 191. Global Bioabsorbable Stents Market Size, by Country, 2017-2032 (USD Million)
TABLE 192. United States Bioabsorbable Stents Market Size, 2017-2032 (USD Million)
TABLE 193. United States Bioabsorbable Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 194. United States Bioabsorbable Stents Market Size, by Metal-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 195. United States Bioabsorbable Stents Market Size, by Polymer-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 196. United States Bioabsorbable Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 197. United States Bioabsorbable Stents Market Size, by Degradation Time, 2017-2032 (USD Million)
TABLE 198. United States Bioabsorbable Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 199. United States Bioabsorbable Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 200. United States Bioabsorbable Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 201. China Bioabsorbable Stents Market Size, 2017-2032 (USD Million)
TABLE 202. China Bioabsorbable Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 203. China Bioabsorbable Stents Market Size, by Metal-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 204. China Bioabsorbable Stents Market Size, by Polymer-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 205. China Bioabsorbable Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 206. China Bioabsorbable Stents Market Size, by Degradation Time, 2017-2032 (USD Million)
TABLE 207. China Bioabsorbable Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 208. China Bioabsorbable Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 209. China Bioabsorbable Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 210. Germany Bioabsorbable Stents Market Size, 2017-2032 (USD Million)
TABLE 211. Germany Bioabsorbable Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 212. Germany Bioabsorbable Stents Market Size, by Metal-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 213. Germany Bioabsorbable Stents Market Size, by Polymer-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 214. Germany Bioabsorbable Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 215. Germany Bioabsorbable Stents Market Size, by Degradation Time, 2017-2032 (USD Million)
TABLE 216. Germany Bioabsorbable Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 217. Germany Bioabsorbable Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 218. Germany Bioabsorbable Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 219. United Kingdom Bioabsorbable Stents Market Size, 2017-2032 (USD Million)
TABLE 220. United Kingdom Bioabsorbable Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 221. United Kingdom Bioabsorbable Stents Market Size, by Metal-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 222. United Kingdom Bioabsorbable Stents Market Size, by Polymer-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 223. United Kingdom Bioabsorbable Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 224. United Kingdom Bioabsorbable Stents Market Size, by Degradation Time, 2017-2032 (USD Million)
TABLE 225. United Kingdom Bioabsorbable Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 226. United Kingdom Bioabsorbable Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 227. United Kingdom Bioabsorbable Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 228. India Bioabsorbable Stents Market Size, 2017-2032 (USD Million)
TABLE 229. India Bioabsorbable Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 230. India Bioabsorbable Stents Market Size, by Metal-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 231. India Bioabsorbable Stents Market Size, by Polymer-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 232. India Bioabsorbable Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 233. India Bioabsorbable Stents Market Size, by Degradation Time, 2017-2032 (USD Million)
TABLE 234. India Bioabsorbable Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 235. India Bioabsorbable Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 236. India Bioabsorbable Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 237. Japan Bioabsorbable Stents Market Size, 2017-2032 (USD Million)
TABLE 238. Japan Bioabsorbable Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 239. Japan Bioabsorbable Stents Market Size, by Metal-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 240. Japan Bioabsorbable Stents Market Size, by Polymer-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 241. Japan Bioabsorbable Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 242. Japan Bioabsorbable Stents Market Size, by Degradation Time, 2017-2032 (USD Million)
TABLE 243. Japan Bioabsorbable Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 244. Japan Bioabsorbable Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 245. Japan Bioabsorbable Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 246. France Bioabsorbable Stents Market Size, 2017-2032 (USD Million)
TABLE 247. France Bioabsorbable Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 248. France Bioabsorbable Stents Market Size, by Metal-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 249. France Bioabsorbable Stents Market Size, by Polymer-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 250. France Bioabsorbable Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 251. France Bioabsorbable Stents Market Size, by Degradation Time, 2017-2032 (USD Million)
TABLE 252. France Bioabsorbable Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 253. France Bioabsorbable Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 254. France Bioabsorbable Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 255. Brazil Bioabsorbable Stents Market Size, 2017-2032 (USD Million)
TABLE 256. Brazil Bioabsorbable Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 257. Brazil Bioabsorbable Stents Market Size, by Metal-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 258. Brazil Bioabsorbable Stents Market Size, by Polymer-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 259. Brazil Bioabsorbable Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 260. Brazil Bioabsorbable Stents Market Size, by Degradation Time, 2017-2032 (USD Million)
TABLE 261. Brazil Bioabsorbable Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 262. Brazil Bioabsorbable Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 263. Brazil Bioabsorbable Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 264. Canada Bioabsorbable Stents Market Size, 2017-2032 (USD Million)
TABLE 265. Canada Bioabsorbable Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 266. Canada Bioabsorbable Stents Market Size, by Metal-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 267. Canada Bioabsorbable Stents Market Size, by Polymer-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 268. Canada Bioabsorbable Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 269. Canada Bioabsorbable Stents Market Size, by Degradation Time, 2017-2032 (USD Million)
TABLE 270. Canada Bioabsorbable Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 271. Canada Bioabsorbable Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 272. Canada Bioabsorbable Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 273. Italy Bioabsorbable Stents Market Size, 2017-2032 (USD Million)
TABLE 274. Italy Bioabsorbable Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 275. Italy Bioabsorbable Stents Market Size, by Metal-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 276. Italy Bioabsorbable Stents Market Size, by Polymer-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 277. Italy Bioabsorbable Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 278. Italy Bioabsorbable Stents Market Size, by Degradation Time, 2017-2032 (USD Million)
TABLE 279. Italy Bioabsorbable Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 280. Italy Bioabsorbable Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 281. Italy Bioabsorbable Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 282. Mexico Bioabsorbable Stents Market Size, 2017-2032 (USD Million)
TABLE 283. Mexico Bioabsorbable Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 284. Mexico Bioabsorbable Stents Market Size, by Metal-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 285. Mexico Bioabsorbable Stents Market Size, by Polymer-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 286. Mexico Bioabsorbable Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 287. Mexico Bioabsorbable Stents Market Size, by Degradation Time, 2017-2032 (USD Million)
TABLE 288. Mexico Bioabsorbable Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 289. Mexico Bioabsorbable Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 290. Mexico Bioabsorbable Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 291. Russia Bioabsorbable Stents Market Size, 2017-2032 (USD Million)
TABLE 292. Russia Bioabsorbable Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 293. Russia Bioabsorbable Stents Market Size, by Metal-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 294. Russia Bioabsorbable Stents Market Size, by Polymer-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 295. Russia Bioabsorbable Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 296. Russia Bioabsorbable Stents Market Size, by Degradation Time, 2017-2032 (USD Million)
TABLE 297. Russia Bioabsorbable Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 298. Russia Bioabsorbable Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 299. Russia Bioabsorbable Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 300. Spain Bioabsorbable Stents Market Size, 2017-2032 (USD Million)
TABLE 301. Spain Bioabsorbable Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 302. Spain Bioabsorbable Stents Market Size, by Metal-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 303. Spain Bioabsorbable Stents Market Size, by Polymer-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 304. Spain Bioabsorbable Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 305. Spain Bioabsorbable Stents Market Size, by Degradation Time, 2017-2032 (USD Million)
TABLE 306. Spain Bioabsorbable Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 307. Spain Bioabsorbable Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 308. Spain Bioabsorbable Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 309. Australia Bioabsorbable Stents Market Size, 2017-2032 (USD Million)
TABLE 310. Australia Bioabsorbable Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 311. Australia Bioabsorbable Stents Market Size, by Metal-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 312. Australia Bioabsorbable Stents Market Size, by Polymer-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 313. Australia Bioabsorbable Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 314. Australia Bioabsorbable Stents Market Size, by Degradation Time, 2017-2032 (USD Million)
TABLE 315. Australia Bioabsorbable Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 316. Australia Bioabsorbable Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 317. Australia Bioabsorbable Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 318. South Korea Bioabsorbable Stents Market Size, 2017-2032 (USD Million)
TABLE 319. South Korea Bioabsorbable Stents Market Size, by Material, 2017-2032 (USD Million)
TABLE 320. South Korea Bioabsorbable Stents Market Size, by Metal-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 321. South Korea Bioabsorbable Stents Market Size, by Polymer-based Bioabsorbable Stents, 2017-2032 (USD Million)
TABLE 322. South Korea Bioabsorbable Stents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 323. South Korea Bioabsorbable Stents Market Size, by Degradation Time, 2017-2032 (USD Million)
TABLE 324. South Korea Bioabsorbable Stents Market Size, by Application, 2017-2032 (USD Million)
TABLE 325. South Korea Bioabsorbable Stents Market Size, by End User, 2017-2032 (USD Million)
TABLE 326. South Korea Bioabsorbable Stents Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 327. Global Bioabsorbable Stents Market Share, by Key Player, 2025
TABLE 328. Global Bioabsorbable Stents Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • Amaranth Medical, Inc.
  • Arterius Ltd
  • B. Braun SE
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Cardionovum GmbH
  • Elixir Medical Corporation
  • ELLA – CS, s.r.o.
  • JW Medical Systems Ltd. Biosensors International Group, Ltd.
  • Kaneka Corporation
  • Kyoto Medical Planning Co. Ltd.
  • Lepu Medical Technology Co. Ltd.
  • Meril Life Sciences
  • Microport Scientific Corporation
  • OrbusNeich Medical Group Holdings Limited
  • Q3 Medical Group
  • Reva Medical
  • SafeGuard Surgical, Inc.
  • Shandong Hua'an Biotechnology
  • Sino Medical Sciences Technology Inc.
  • Svelte Medical Systems Inc
  • Terumo Corporation
  • WEGO HEALTHCARE (SHENZHEN) CO., LTD
  • Zorion Medical Inc.

Table Information

Report AttributeDetails
No. of Pages185
PublishedSeptember 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 645.65 Million
Forecasted Market Value ( USD ) by 2032 $ 952.71 Million
Compound Annual Growth Rate6.6%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Bioabsorbable Stents Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Bioabsorbable Stents Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Bioabsorbable Stents Market Report by Biomaterial, Absorption Rate, Application, End User, and Region 2026-2034 - Product Image

Bioabsorbable Stents Market Report by Biomaterial, Absorption Rate, Application, End User, and Region 2026-2034

  • Report
  • 150 Pages
  • Global
From
Bioabsorbable Stents Market Report 2026 - Product Image

Bioabsorbable Stents Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Bioabsorbable Stents - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Bioabsorbable Stents - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 120 Pages
  • Global
From
Bioresorbable Stents - Global Strategic Business Report - Product Image

Bioresorbable Stents - Global Strategic Business Report

  • Report
  • 125 Pages
  • Global
From

About the Bioabsorbable Stent Market

The Bioabsorbable Stent market is a subset of the larger Stent market. Bioabsorbable Stents are medical devices used to treat coronary artery disease. They are made of biodegradable materials that dissolve over time, allowing the artery to return to its natural state. This type of stent is advantageous over traditional metal stents, as it eliminates the need for a second procedure to remove the stent. Bioabsorbable Stents are also beneficial in that they reduce the risk of restenosis, a condition in which the artery becomes blocked again after stent placement. Notable companies in the Bioabsorbable Stent market include Abbott, Biotronik, Elixir Medical, and Biosensors International. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.